CARDIOVASCULAR DISEASE RISKS AND FACTORS INFLUENCING THEM AMONG MEDICAL COLLEGE STUDENTS

Rita Geske, Alevtīna Leice, Madara Miķelsone

Abstract


The aim of the study is to identify the CVD risks among medical college students associating them to their lifestyle. It should be noted that cardiovascular diseases also affect young people, which students are also. Information obtained during research is necessary for prospective medical staff to acknowledge their cardiovascular health and its influencing factors, as well as for college lecturers to make changes in study programs. The theoretical part of the research discusses various CVD risk determination methods, as well as lifestyle`s impact on cardiovascular health. The empirical part of the research contains information about ten years CVD risk among students, using two Framingham methods (based on the body mass index and amount of lipids in the blood) and seven risk factor (blood pressure, body mass index, smoking, total cholesterol, triglycerides, high-density cholesterol and glucose) addition method.

 


Keywords


CVD risks; Framingham methods lifestyle`s impact on cardiovascular health; medical college students

Full Text:

PDF

References


Augstkalne, D. (2007). Fiziskās slodzes ietekme uz sirds asinsvadu sistēmu, Doctus, 8, 23-27.

Baik, I., Ascherio, A., Rimm, E.B. et al. (2000). Adiposity and mortality in men. American Journal Epidemiology, 152, 264-271.

Benjamin, R., et al. (2010) How Tobacco Smoke Disease:The Biology and Behavioral Basis for Smoking - Atributable Disease, Report on the Surgeon General Asambly.

Berenson, G.S. et al. (1998). Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults, N Engl J Med., 338,1650-1656.

Boutayeb, A. (2006). The double burden of communicable and non-comunicable diseases in developing countries, Trans R Soc.Trop Med Hyg, 100, 191-199.

Conroy, R.M. et al. (2003). Estimation often-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart Jornal, 24, 987–1003.

Council conclusions on promoting heart health. (2004) Council of the European Union, Brussels, 9 March.

D’Agostino R.B. et al. (2008). General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 117, 743– 753.

Daly, M. (2007). Sugars, insulin sensitivity, and the postprandial state, Amer.J.Clin.Nutr., 78,. 865S–872S.

Denke, M.A., Sempos, C.T., Grundy, S,M. (1993). Excess body weight: an underrecognized contributor to high blood cholesterole vels in white American men, Arch Intern Med, 153, 1093-1103.

Ērglis, A. u.c. (2012). Smēķēšanas posts un kardiovaskulārās slimības. Latvijas ārsts, 11, 19-22.

Ērglis, A., et al. (2012). Population-Based Cross-Sectional Study of Cardiovascular Risk Faktor in Latvia, Medicina, 48 (6), 310-316.

Gielen, S. et al. (2015). The ESC Textbook of Preventive Cardiology, Oxford.

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. (1999). Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe, Lancet, 354(9179), 617-621.

Hedner,T., Hansson, I., Jern, S. (1996). What is happening to blood pressuare? Blood Press, May, 5 (3):132-133.

Krams, A. (2012). Vēlreiz par tabakas smēķēšanu. Ārsts, 11, 23-27.

Latvijas veselības aprūpes statististikas gadagrāmata. (2014). Slimību profilakses un kontroles centrs. http://www.spkc.gov.lv/veselibas-aprupes-statistika/

Lewingtom, S., et al. (2002). Age specific relevance of usual blood pressure to vascular mortallity: a meta analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1930-1913.

Lloyd-Jones, D.M., et al. (2010). Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation, 121, 586–613.

Mintāle, I. (2014). Veselīgs uzturs kardiologa skatījumā. Latvijas Ārsts, 10, 63–66.

Oliveira, F.L.C., et al. (2010). Atherosclerosis prevention and treatment in children and adolescents, Expert Rev Ther, 8(4), 513-528.

Pecorelli, S. (2013). The Prescription of Physical Exercise: a Pillar for European Sport Medicine, Congress of EFSMA, Strasbourg, September 25-28,

Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., et al. (2012). European Guidelines on cardiovascular disease prevention in clinical practice: The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice, Eur Heart Journal, 33, 1635–1701.

Raitakan, O. et all. (2004).The Cardiovascular risk in Yuong Finns study, Acta Paediatric, 446, 34-42.

Retelny, S., Neuendorf, A., Julie L. Roth, J.R. (2008). Nutrition protocols for the prevention of cardiovascular disease, Nutr Clin Pract, 23 (5),468-476. doi: 10.1177/0884533608323425.

Sauka, M. (2015). Konsultācija par fizisko aktivitāti – neatņemama veselības aprūpes sastāvdaļa, Latvijas ārsts, jūnijs/jūlijs, 90-92.

Stahl, T., Wismar, M., Ollila, E., Lahtinen, E., & Leppo, K. (2006). Health in All Policies Prospects and potentials, Ministry of Social Affairs and Health, Health DepartmentFinland

Strong, J.P. et al. (1999). Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study, JAMA, 281, 727–735.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. (2002). Circulation, 106(25), 3143-3421.

Vetsmane, V. (2014). Hipertensijas trīs tipu pacenti. Latvijas ārsts, 2, 43-50.

Yusuf, S., Ounpuu, S., & Anand, S. (2002). The Global Epidemic of Atherosclerotic Cardiovascular Disease. Medical Principles and Practice, 11(S2), 3-8.

Yusuf,S. et al. (2004). Effect of potentially modifable risk factors assocated with myocardilal infarction in 52 countries (the INTRHEART study ): case –control study. The Lancet, 364(9438), 937-952.

Погожева, А.В., (2004). Основы рациональной диетотерапии при сердечно–сосудистых заболеваниях, Клиническая диетология,1 (2),17–29.

Шарафетдинов, Х.Х. , Плотникова, О.А. (2007). Диетическая коррекция нарушений липидного обмена при метаболическом синдроме, Кардиология «РМЖ», 9, 697.





DOI: http://dx.doi.org/10.17770/sie2016vol3.1465

Refbacks

  • There are currently no refbacks.